Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
Vous pourriez aussi aimer
À la hausse
Dernières actus crypto
Réunions futures de la Fed Risque de voir augmenter les désaccords alimentant la volatilité du marché
Tom Lee: Le rapport risque-rendement des CTB et des EPF devient très attractif
Coinbase est maintenant en ligne avec Rayls (RLS) spot trading
Une certaine adresse de baleine a déposé 10 millions d'U dans HyperLiquid, initiant une position longue ETH 20x.
Coinbase to List Rayls (RLS)
Assistance client:@weikecs
Collaborations commerciales:@weikecs
Trading quantitatif/Market makers:[email protected]
Programme VIP:[email protected]